GE HealthCare Technologies Inc. (GEHC)

Here is how GE HealthCare Technologies (GEHC) and Brookdale Senior Living (BKD) have performed compared to their sector so far this year.

GEHC wins FDA clearance for three SIGNA MRI innovations, boosting AI-driven workflows, sustainability and precision imaging capabilities.

The FDA has recently approved GE HealthCare's next-generation SIGNA MRI technology, which is designed to enhance precision imaging and clinical efficiency. This milestone is significant as it includes the SIGNA Sprint with Freelium technology, aiming to reduce helium dependency—a critical advancement in making MRI technology more sustainable and cost-effective.

Advisors Capital Management LLC purchased a new position in shares of GE HealthCare Technologies Inc. (NASDAQ: GEHC) in the undefined quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 11,187 shares of the company's stock, valued at approximately $840,000. Several other large investors have also

Insulet (NASDAQ: PODD - Get Free Report) and GE HealthCare Technologies (NASDAQ: GEHC - Get Free Report) are both large-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, profitability, analyst recommendations, earnings, valuation and risk. Volatility and Risk Insulet has a beta

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) announced today 510(k) clearance of three new magnetic resonance (MR) innovations with the U.S. Food and Drug Administration (FDA): SIGNA™ Sprint with Freelium™1, a 1.5T sealed magnet MRI system; SIGNA™ Bolt2, an advanced 3T MRI scanner; and SIGNA™ One3, an AI-driven ecosystem of workflow solutions designed to help reduce inefficiencies and support MRI exams from plan to scan and beyond. The new MRI systems and technology combat some of the.

GE HealthCare expands its BARDA deal by $35M to speed AI-enabled ultrasound and next-gen imaging for trauma care and mass casualty readiness.

Exploring the Latest 13F Filing and Investment Strategies Nelson Peltz (Trades, Portfolio) recently submitted the 13F filing for the fourth quarter of 2025, pr

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced a new approximately $35 million expansion to a previous contract with the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS). The expansion is structured as a cost-share between BARDA and GE HealthCare, with BARDA providing the majority of funding. This jointly funded expanded a.

GE HealthCare Technologies (NASDAQ: GEHC - Get Free Report) and Curaleaf (OTCMKTS:CURLF - Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, profitability, risk, earnings, analyst recommendations and valuation. Insider and Institutional Ownership 82.1% of GE HealthCare

CENTRAL TRUST Co lifted its stake in shares of GE HealthCare Technologies Inc. (NASDAQ: GEHC) by 58.7% during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 18,396 shares of the company's stock after acquiring an additional 6,805 shares during the

Caprock Group LLC bought a new stake in GE HealthCare Technologies Inc. (NASDAQ: GEHC) in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 22,565 shares of the company's stock, valued at approximately $1,664,000. Several other institutional investors and hedge funds have also

CHICAGO--(BUSINESS WIRE)--The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the first quarter of 2026 payable on May 15, 2026, to all shareholders of record as of April 3, 2026. About GE HealthCare Technologies Inc. GE HealthCare is a leading global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud and software solutions that help clinicians tackle.

Insight into the Fourth Quarter 2025 13F Filing Barrow, Hanley, Mewhinney and Strauss (Trades, Portfolio) recently submitted their 13F filing for the fourth quar

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) is announcing that members of its management team will present at the following upcoming investor conferences. Citi's 2026 Unplugged MedTech and Life Sciences Access Day – Thursday, February 26, 2026 at 9:30 am ET/8:30 am CT Barclays 28th Annual Global Healthcare Conference – Tuesday, March 10, 2026 at 8:00 am ET/7:00 am CT Webcasts for each event can be accessed on the GE HealthCare website: https://investor.gehealthcare.com/news-events/ev.

Investors with an interest in Medical - Products stocks have likely encountered both GE HealthCare Technologies (GEHC) and Stryker (SYK). But which of these two companies is the best option for those looking for undervalued stocks?